ResearchPLTR24 days ago2.7Kviews

Re-rating path for PLTR

Healthcare: PLTR over 60 days — demo research by @fatima_alhariri.

Fatima Al-Hariri on PLTR. PhD pharmacology. I focus on PDUFA dates, trial readouts, and mispriced optionality in mid-cap biotech. Thesis: long over 60 days. Entry locked at publication. Risk: macro shock overwhelms the single-name view. [Demo seed content — not investment advice.]

Re-rating path for PLTR

Discussion (0)